Filing Flows › Axsome Therapeutics (AXSM) › Royalty and Milestone Revenue revenue
Axsome Therapeutics (AXSM) Royalty and Milestone Revenue revenue by quarter
Axsome Therapeutics' Royalty and Milestone Revenue revenue was $9.7M in Q3 2026 (third quarter 2026), +382% from Q2 2026. Over the last 3 quarters it ranged from $1.8M (Q1 2026) to $9.7M (Q3 2026).
| Quarter | Royalty and Milestone Revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $9.7M | +382% | — |
| Q2 2026 | $2.0M | +12% | — |
| Q1 2026 | $1.8M | — | — |
Q3 2026 at a glance
Axsome Therapeutics, Q3 2026: revenue $260M (+52% year over year), operating margin -4.3%, net loss $12.9M, operating cash flow −$9.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Axsome Therapeutics' Royalty and Milestone Revenue revenue?
Axsome Therapeutics' Royalty and Milestone Revenue revenue was $9.7M in Q3 2026 (third quarter 2026), +382% from Q2 2026.
How has Axsome Therapeutics' Royalty and Milestone Revenue revenue changed?
Over the last 3 quarters it ranged from $1.8M (Q1 2026) to $9.7M (Q3 2026).